Company
uniQure N.V. (QURE)
Standardized SEC financial data for uniQure N.V. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001590560 · NASDAQ · Pharmaceutical Preparations.
Gross margin
89.5%
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-40.6%
Return on equity
-100.0%
ROIC
-76.8%
Free cash flow
-$178.4M
Debt / equity
0.36×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $37.5M | $524.0M | $106.5M | $15.8M | $27.1M | $16.1M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $247.7M | $559.4M | $231.2M | $244.5M | $160.3M | $81.8M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$134.8M | $288.0M | -$145.1M | -$145.9M | -$182.7M | -$178.0M |
| Capital expenditures |
Get QURE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/QURE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/QURE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"